Infectious Disease Doctors in Midlothian, VA Accepting Medicare

3 Infectious Disease doctors found. Showing 1 - 3

Mark A Gentz, D.O. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 505, Midlothian, VA 23114 Phone: 804-601-0609    Fax: 804-594-7424

Dr. Sarika S Tripathi, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13107 Handley Ct, Midlothian, VA 23113 Phone: 804-833-5765    Fax: 804-445-2041

Andrea Gonzalez, M.D. Internal Medicine - Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 13700 Saint Francis Blvd, Suite 510, Midlothian, VA 23114 Phone: 804-276-7125    Fax: 804-276-7126

News Archive

Scientific American examines relationship between climate change, health

Scientific American examines the interface between climate change and human health, writing, "WHO research suggests that current warming of global average temperatures of just under one degree Celsius is responsible for an additional 150,000 deaths per year, largely due to agricultural failures and diarrheal disease in developing countries.

Adults have much more "brown fat" than previously thought

Keeping your baby fat turns out to be a good thing, as long as it is "brown fat" - the kind that burns calories, according to a study that found adults have much more of this type of fat than previously thought.

Irrational health beliefs associated with lower adherence to prescribed cardiac rehab program, says study

​Heart patients with beliefs about health that aren't based on medical evidence are more likely to skip sessions of cardiac rehabilitation, new research suggests.

AVEO's RON antibody shows anti-tumor activity in human cancer xenografts

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data from AVEO's anti-RON antibody program which demonstrated the successful identification of antibodies with potent anti-tumor activity that demonstrated inhibition of the function of both wild type RON and the RONΔ160 variant, as well as a potential biomarker to identify tumors likely to respond to treatment with the anti-RON antibody.

Read more Medical News

› Verified 4 days ago